ScholarIQanswers from OpenAlex & ORCID
Mark E. Dudley
ResearcherPublications, citations & collaboration network
Mark E. Dudley is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark E. Dudley have?
ScholarIQindexed works
Mark E. Dudley has 208 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark E. Dudley have?
ScholarIQcitation count
Mark E. Dudley has 47,005 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark E. Dudley?
ScholarIQh-index
Mark E. Dudley has an h-index of 67 in OpenAlex.
What is the i10-index of Mark E. Dudley?
ScholarIQi10-index
Mark E. Dudley has an i10-index of 109 in OpenAlex.
What is the OpenAlex record for Mark E. Dudley?
ScholarIQopenalex
The OpenAlex for Mark E. Dudley is on the source record.
What are the most-cited papers on Mark E. Dudley?
ScholarIQmost cited works
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Mark E. Dudley, Susan Schwarz, Paul J. Spiess, Maria R. Parkhurst, Yutaka Kawakami, Claudia A. Seipp, Jan Einhorn, Donald E. White
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg